AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-6.53%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$97.4M
AUM Growth
–
Cap. Flow
+$97.4M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
184
New
184
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$12.8M |
| 2 |
Rithm Capital
RITM
|
$3.2M |
| 3 |
Mr. Cooper
COOP
|
$2.14M |
| 4 |
Sanofi
SNY
|
$2.11M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$2.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.93% |
| 2 | Real Estate | 12% |
| 3 | Financials | 8.32% |
| 4 | Technology | 3.61% |
| 5 | Industrials | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elanco Animal Health
ELAN
$9.12B
| $962K | 0.99% |
+77,500
| New | +$962K |
|
27
Intuitive Surgical
ISRG
$170B
| $937K | 0.96% |
+5,000
| New | +$937K |
|
|
MOR
28
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $931K | 0.96% |
+185,000
| New | +$931K |
|
29
Aveanna Healthcare
AVAH
$1.67B
| $900K | 0.92% |
+600,000
| New | +$900K |
|
30
Stereotaxis
STXS
$261M
| $900K | 0.92% |
+500,000
| New | +$900K |
|
31
Enact Holdings
ACT
$5.55B
| $898K | 0.92% |
+40,512
| New | +$898K |
|
32
BioCryst Pharmaceuticals
BCRX
$1.74B
| $882K | 0.91% |
+70,000
| New | +$882K |
|
33
Omnicell
OMCL
$1.5B
| $870K | 0.89% |
+10,000
| New | +$870K |
|
34
Vuzix
VUZI
$164M
| $869K | 0.89% |
+150,000
| New | +$869K |
|
35
Ametek
AME
$42.7B
| $851K | 0.87% |
+7,500
| New | +$851K |
|
|
NYMT
36
New York Mortgage Trust
NYMT
$652M
| $848K | 0.87% |
+362,339
| New | +$848K |
|
|
FSTX
37
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $845K | 0.87% |
+165,000
| New | +$845K |
|
38
Gilead Sciences
GILD
$140B
| $833K | 0.85% |
+13,500
| New | +$833K |
|
|
ONIT
39
Onity Group Inc.
ONIT
$333M
| $829K | 0.85% |
+35,618
| New | +$829K |
|
40
Innoviva
INVA
$1.29B
| $789K | 0.81% |
+68,000
| New | +$789K |
|
41
Embecta
EMBC
$847M
| $777K | 0.8% |
+27,000
| New | +$777K |
|
|
RWT
42
Redwood Trust
RWT
$791M
| $754K | 0.77% |
+131,398
| New | +$754K |
|
|
TARO
43
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $735K | 0.75% |
+24,500
| New | +$735K |
|
44
Accuray
ARAY
$157M
| $728K | 0.75% |
+350,000
| New | +$728K |
|
45
Viridian Therapeutics
VRDN
$1.5B
| $728K | 0.75% |
+35,500
| New | +$728K |
|
46
Welltower
WELL
$113B
| $711K | 0.73% |
+11,059
| New | +$711K |
|
47
Bio-Rad Laboratories Class A
BIO
$8.06B
| $709K | 0.73% |
+1,700
| New | +$709K |
|
48
MGIC Investment
MTG
$6.42B
| $691K | 0.71% |
+53,900
| New | +$691K |
|
49
AirSculpt Technologies
AIRS
$403M
| $688K | 0.71% |
+107,000
| New | +$688K |
|
|
SLGC
50
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $660K | 0.68% |
+227,500
| New | +$660K |
|